U.S. Insurance Stock News

ReNew Energy Global Plc recently reported its first quarter FY26 results, recording INR41.18 billion in revenue and a net profit of INR5.13 billion, both showing significant year-over-year increases. The company's clean power capacity grew by 23% and ReNew surpassed analyst revenue estimates, while also reiterating guidance for continued capacity and operational expansion. We’ll explore how ReNew’s robust profit jump and clean energy capacity growth may shape the company’s longer-term...

National HealthCare Corporation recently reported its second quarter and six-month 2025 financial results, highlighting year-over-year revenue growth and confirming a quarterly dividend of US$0.64 per share for shareholders of record on September 30, 2025, payable on October 31, 2025. The combination of higher revenue and the continuation of regular dividend payments underscores the company’s commitment to returning value to shareholders despite a lower quarterly net income. We'll explore...

Earlier this month, Collegium Pharmaceutical reported a decrease in net income and earnings per share for the second quarter and first half of 2025 compared to the previous year, but raised its full-year net product revenue guidance and updated its buyback activity, including the repurchase of 692,281 shares for US$20.01 million during the last quarter. This combination of weaker earnings with increased revenue expectations and an ongoing share buyback program highlights a balancing act...

BeOne Medicines Ltd. recently reported second quarter 2025 earnings, showing revenue of US$1.32 billion and net income of US$94.32 million, marking a reversal from net losses in the previous year. The company also raised its full-year 2025 revenue guidance and now expects positive GAAP operating income, highlighting improved operational performance and momentum in its oncology business. We'll explore how BeOne's move to profitability and higher revenue guidance affect its investment...

AbCellera Biologics reported its second quarter and six-month earnings, showing quarterly revenue of US$17.08 million, more than doubling from a year ago, while six-month revenue reached US$21.32 million. Despite ongoing net losses, the strong revenue growth compared to the prior year signals business progress and could shift perceptions on the company’s operational momentum. We’ll examine how this recent revenue surge may affect the company’s outlook and the broader investment...

Travere Therapeutics recently announced its second quarter 2025 earnings, reporting revenue of US$114.45 million, compared to US$54.12 million for the same period last year, and a net loss of US$12.76 million versus US$70.41 million previously. This substantial year-over-year improvement in both revenue and net loss underscores the company's operational progress and strengthens its financial foundation. We'll explore how significant revenue gains and improved earnings performance influence...

Oscar Health, Inc. and Hy-Vee, Inc. recently unveiled a new employer health insurance plan combining Oscar’s technology platform with Hy-Vee’s retail and pharmacy network, offering concierge care and $0 cost services for employees through the “Hy-Vee Health with Oscar” program. This collaboration introduces a comprehensive suite of health and shopping benefits, aiming to simplify healthcare delivery for employees while helping employers manage costs. We’ll explore how Oscar’s entry...

Earlier this month, IREN Limited announced its July 2025 operating results, reporting an average operating hashrate of 45.4 EH/s and 728 Bitcoin mined. The detailed disclosure of monthly mining output offers insight into IREN's ongoing capacity and efficiency, key metrics for evaluating cryptocurrency mining companies. To assess how these latest production figures impact the company's outlook, we'll explore what IREN's recent operating performance means for its evolving investment...

CRISPR Therapeutics reported its second quarter and half-year 2025 financial results, highlighting revenue growth to US$892,000 for the quarter and US$1.76 million for the half-year, but also a widening net loss to US$208.55 million and US$344.55 million respectively. This widening gap between higher revenue and increased net losses underlines the company’s ongoing investment in research and development and the challenges of commercializing advanced gene-editing therapies. We’ll explore how...

Earlier this month, Rubrik, Inc. unveiled Agent Rewind, a new AI-driven data recovery solution built on Predibase technology and announced shortly after closing its acquisition of Predibase. This launch directly addresses the growing risks of autonomous AI errors in enterprise environments by enabling organizations to fully audit and safely reverse problematic actions made by AI agents, enhancing trust and resilience in emerging AI deployments. We'll now explore how Agent Rewind's ability to...

Liberty Broadband reported strong earnings for the second quarter ended June 30, 2025, with sales rising to US$261 million and net income increasing to US$383 million from the previous year. Despite not repurchasing any shares in the latest quarter, the company has completed a massive buyback program totaling nearly 34.2% of its outstanding shares since 2016, amounting to over US$8.1 billion. We’ll examine how Liberty Broadband’s significant year-over-year net income growth updates its...

Earlier this month, Oddity Tech Ltd. reported second quarter sales of US$241.14 million and net income of US$49.29 million, also raising its full-year 2025 net revenue guidance to a new range of US$799 million to US$804 million. This upward revision to revenue targets following robust quarterly results highlights the company’s confidence in its operating momentum and future demand outlook. We’ll explore how Oddity Tech’s strengthened full-year guidance, reflecting accelerating business...

Coeur Mining announced its second quarter 2025 results, highlighting sales of US$480.65 million and net income of US$70.73 million, with strong increases in both gold and silver production figures compared to the same period last year. Alongside these results, the company reaffirmed its annual production guidance for both metals and completed a share buyback, signaling a focus on operational discipline and capital allocation. With Coeur delivering a sharp rise in production and profits,...

Globus Medical reported strong second-quarter 2025 results, with sales of US$745.34 million and net income of US$202.85 million, along with reaffirmed full-year revenue guidance of US$2.80 billion to US$2.90 billion. The company completed a share buyback of 411,000 shares for US$24.99 million, signaling ongoing confidence in its capital allocation strategy. We’ll now explore how Globus Medical’s robust earnings growth and reaffirmed guidance influence its broader investment narrative. We've...

Ascendis Pharma released its second quarter and half-year 2025 financial results, reporting sales of €158.05 million and €259 million, respectively, with both periods showing sharply reduced net losses compared to the previous year. This marked improvement in revenue and narrowing of net loss highlights the company's progress toward greater financial stability and operational efficiency as of June 30, 2025. We'll explore how the substantial year-over-year revenue growth and reduced net loss...

In recent days, Trump Media & Technology Group Corp. announced a series of product and content expansion moves, including adding GB News to Truth+, launching an on-demand slate from Great American Media, and beginning public Beta testing of an AI-powered search feature for Truth Social. These developments mark the company’s continued push to broaden its global reach and diversify its digital streaming and engagement offerings through technology-driven features. We'll explore how the launch...

On August 11, 2025, Fluence Energy reaffirmed its fiscal year 2025 revenue guidance at a range of US$2.6 billion to US$2.8 billion, but now expects to reach the lower end of the range due to slower production ramp-up at its new U.S. manufacturing facilities, shifting some anticipated revenue to fiscal year 2026. This delay in production comes as the company maintains its annual recurring revenue guidance and expects the facilities to achieve target capacity by year-end, bolstering its...

NANO Nuclear Energy Inc. recently announced earnings results for the quarter and nine months ended June 30, 2025, reporting a third-quarter net loss of US$7.59 million and a year-to-date net loss of US$32.02 million, both higher than the prior year. Losses per share also widened from the previous year, suggesting increased operational costs or investments contributing to the deeper losses. We'll examine how the larger net loss shapes NANO Nuclear Energy's investment narrative around future...

Stride, Inc. recently reported fourth quarter and full year earnings, highlighting sales growth to US$653.65 million for the quarter and US$2.41 billion for the year, while also posting a very large US$59.48 million impairment charge and sharing details of a new partnership to operate Destinations Career Academy of New Mexico. Despite higher full-year sales and net income, the company's quarterly profitability was reduced year-over-year, reflecting the impact of the impairment charge and...

CF Industries Holdings released its second-quarter 2025 results, reporting US$1.89 billion in sales, steady ammonia production, and updates on share repurchase activity completed under its ongoing buyback program. Notably, management issued full-year guidance projecting gross ammonia output to reach approximately 10 million tons, highlighting continued focus on production scale and operational efficiency. To understand the potential impact on CF Industries Holdings' investment outlook, we'll...

In August 2025, Raymond James upgraded Essex Property Trust to Outperform, emphasizing the company's robust presence in tech-driven West Coast markets and noting improving cash delinquencies as well as early signs of rent growth recovery in Oakland. The upgrade underscores Essex's cost of capital advantage, setting it apart as potentially less exposed to supply pressures affecting multifamily REITs in other regions. We'll now explore how Essex's cost of capital advantage, highlighted in the...

Cboe Global Markets recently filed a US$731.13 million shelf registration for 3,000,000 shares tied to an ESOP-related offering and, one day prior, announced a 14% increase in its quarterly dividend to US$0.72 per share for Q3 2025. This dividend hike highlights the company's confidence in its financial position and potential to return value to shareholders. We’ll explore how Cboe’s dividend increase signals financial strength and could influence the stock’s future investment outlook. The...

Harmony Biosciences Holdings recently reported second-quarter 2025 earnings, revealing net income of US$39.78 million versus US$11.59 million a year earlier and reaffirmed its full-year 2025 revenue guidance of US$820 million to US$860 million. This sharp improvement in earnings and maintained revenue outlook highlights the company’s operational momentum and management’s confidence in its ongoing business performance. With Harmony Biosciences delivering much higher profits and upholding its...

Earlier this month, Sunrun announced a rapid migration of its operations to Oracle Warehouse Management Cloud and reported strong second-quarter earnings with net income of US$279.77 million, more than doubling year over year. An independent study released by The Brattle Group also revealed that Sunrun's fleet of over 100,000 residential batteries supplied the majority of distributed energy during a major California grid event, underscoring the company's growing influence in the home energy...